Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Bonaventura Clotet and Jordi Puig.
Bonaventura Clotet
Connection Strength
0.296
Jordi Puig
  1. Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial. Clin Infect Dis. 2021 12 06; 73(11):e4073-e4081.
    View in: PubMed
    Score: 0.061
  2. High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients. Life Sci Alliance. 2021 09; 4(9).
    View in: PubMed
    Score: 0.060
  3. Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial. Lancet Infect Dis. 2021 10; 21(10):1365-1372.
    View in: PubMed
    Score: 0.059
  4. SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity. Sci Rep. 2021 01 28; 11(1):2608.
    View in: PubMed
    Score: 0.058
  5. A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19. N Engl J Med. 2021 02 04; 384(5):417-427.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.